Log In
Print this Print this

Buprenorphine Sublingual Spray

  Manage Alerts
Collapse Summary General Information
Company Insys Therapeutics Inc.
DescriptionSublingual spray formulation of buprenorphine
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat moderate to severe postoperative pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today